(Q47276298)

English

Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

multiple sclerosis

0 references

Grazia Maria Liuzzi

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Tiziana Latronico

object named as

Tiziana Latronico

2

0 references

author name string

Anna Fasano

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Giulia Carlone

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Paolo Riccio

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

10

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

290-297

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Matrix metalloproteinases in neuroinflammation

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Isolation of the N-terminal globular protein domains from cartilage proteoglycans. Identification of G2 domain and its lack of interaction with hyaluronate and link protein

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1016OA

21 January 2018

Identifiers

10.1191/1352458504MS1016OA

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15222694

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47276298&oldid=2149718048"